Return to Clinical Trials Search Results

Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions (CLIMB)

Primary Outcome Measures: Accuracy of PCL diagnosis [Time Frame: 48 months] Diagnostic accuracy of confocal laser endomicroscopy and/or cyst fluid molecular markers and/or composite clinical and imaging features for the diagnosis of mucinous PCLs, PCLs with malignant potential, specific PCL types, and mucinous PCLs with advanced neoplasia. Secondary Outcome Measures: Imaging quality [Time Frame: 48 months] Optimal quality of imaging obtained during in vivo confocal laser endomicroscopy of pancreatic cystic lesions

Primary Outcome Measures: Accuracy of PCL diagnosis [Time Frame: 48 months] Diagnostic accuracy of confocal laser endomicroscopy and/or cyst fluid molecular markers and/or composite clinical and imaging features for the diagnosis of mucinous PCLs, PCLs with malignant potential, specific PCL types, and mucinous PCLs with advanced neoplasia. Secondary Outcome Measures: Imaging quality [Time Frame: 48 months] Optimal quality of imaging obtained during in vivo confocal laser endomicroscopy of pancreatic cystic lesions